Martin Javier San, the CHIEF MEDICAL OFFICER of $ATHA, sold 1,644 shares of the company on 01-02-2026 for an estimated $11,310. We received data on the trade from a recent SEC filing. This was a sale of approximately 13.9% of their shares of this class of stock. Following this trade, they now own 10,189 shares of this class of $ATHA stock.
$ATHA Insider Trading Activity
$ATHA insiders have traded $ATHA stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ATHA stock by insiders over the last 6 months:
- MARK JAMES LITTON (President and CEO) sold 2,586 shares for an estimated $17,791
- MARTIN JAVIER SAN (CHIEF MEDICAL OFFICER) sold 1,644 shares for an estimated $11,310
- KEVIN CHURCH (CHIEF SCIENTIFIC OFFICER) sold 876 shares for an estimated $6,026
- MARK WORTHINGTON (General Counsel and CCO) sold 876 shares for an estimated $6,026
- ROBERT RENNINGER (Chief Financial Officer) sold 297 shares for an estimated $2,043
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ATHA Hedge Fund Activity
We have seen 5 institutional investors add shares of $ATHA stock to their portfolio, and 41 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PROPEL BIO MANAGEMENT, LLC removed 149,279 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $618,015
- SIMPLIFY ASSET MANAGEMENT INC. removed 149,279 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $618,015
- TANG CAPITAL MANAGEMENT LLC removed 60,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $248,399
- BANK OF AMERICA CORP /DE/ removed 41,621 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $172,310
- ACADIAN ASSET MANAGEMENT LLC removed 40,548 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $167,868
- BLACKROCK, INC. removed 37,645 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $155,850
- PATHSTONE HOLDINGS, LLC removed 37,220 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $154,090
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
